71 related articles for article (PubMed ID: 22709941)
1. Pitfalls in urinary complement measurements.
van der Pol P; de Vries DK; van Gijlswijk DJ; van Anken GE; Schlagwein N; Daha MR; Aydin Z; de Fijter JW; Schaapherder AF; van Kooten C
Transpl Immunol; 2012 Aug; 27(1):55-8. PubMed ID: 22709941
[TBL] [Abstract][Full Text] [Related]
2. Urinary properdin excretion is associated with intrarenal complement activation and poor renal function.
Siezenga MA; van der Geest RN; Mallat MJ; Rabelink TJ; Daha MR; Berger SP
Nephrol Dial Transplant; 2010 Apr; 25(4):1157-61. PubMed ID: 19934084
[TBL] [Abstract][Full Text] [Related]
3. Urinary Properdin and sC5b-9 Are Independently Associated With Increased Risk for Graft Failure in Renal Transplant Recipients.
Lammerts RGM; Eisenga MF; Alyami M; Daha MR; Seelen MA; Pol RA; van den Born J; Sanders JS; Bakker SJL; Berger SP
Front Immunol; 2019; 10():2511. PubMed ID: 31736953
[TBL] [Abstract][Full Text] [Related]
4. Acute but transient release of terminal complement complex after reperfusion in clinical kidney transplantation.
de Vries DK; van der Pol P; van Anken GE; van Gijlswijk DJ; Damman J; Lindeman JH; Reinders ME; Schaapherder AF; Kooten Cv
Transplantation; 2013 Mar; 95(6):816-20. PubMed ID: 23348894
[TBL] [Abstract][Full Text] [Related]
5. Proteinuria is accompanied by intratubular complement activation and apical membrane deposition of C3dg and C5b-9 in kidney transplant recipients.
Isaksson GL; Nielsen MB; Hinrichs GR; Krogstrup NV; Zachar R; Stubmark H; Svenningsen P; Madsen K; Bistrup C; Jespersen B; Birn H; Palarasah Y; Jensen BL;
Am J Physiol Renal Physiol; 2022 Feb; 322(2):F150-F163. PubMed ID: 34927448
[TBL] [Abstract][Full Text] [Related]
6. Early proteinuria is a strong indicator of donor renal lesions, ischemia-reperfusion injury and immunological aggression.
Halimi J; Laouad I; Buchler M; Al-Najjar A; Chatelet V; Houssaini TS; Nivet H; Lebranchu Y
Transplant Proc; 2006 Sep; 38(7):2319-20. PubMed ID: 16980078
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic roles of urinary kidney injury molecule 1 and soluble C5b-9 in acute tubulointerstitial nephritis.
Zhao WT; Huang JW; Sun PP; Su T; Tang JW; Wang SX; Liu G; Yang L
Am J Physiol Renal Physiol; 2019 Sep; 317(3):F584-F592. PubMed ID: 31291122
[TBL] [Abstract][Full Text] [Related]
8. Functional assessment of rat complement pathway activities and quantification of soluble C5b-9 in an experimental model of renal ischemia/reperfusion injury.
Kotimaa J; van der Pol P; Leijtens S; Klar-Mohammad N; Schilders G; Daha MR; Rutjes H; van Kooten C
J Immunol Methods; 2014 Oct; 412():14-23. PubMed ID: 24953215
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of urinary factor H excretion in patients with idiopathic membranous nephropathy].
Endo M; Fuke Y; Ohi H; Satomura A; Fukuda N; Fujita T; Matsumoto K
Nihon Jinzo Gakkai Shi; 2007; 49(5):499-504. PubMed ID: 17695812
[TBL] [Abstract][Full Text] [Related]
10. Level of complement activity predicts cardiac dysfunction after acute myocardial infarction treated with primary percutaneous coronary intervention.
Haahr-Pedersen S; Bjerre M; Flyvbjerg A; Mogelvang R; Dominquez H; Hansen TK; Galatius S; Bech J; Madsen JK; Søgaard P; Jensen JS
J Invasive Cardiol; 2009 Jan; 21(1):13-9. PubMed ID: 19126922
[TBL] [Abstract][Full Text] [Related]
11. Complement activation products in the urine from proteinuric patients.
Morita Y; Ikeguchi H; Nakamura J; Hotta N; Yuzawa Y; Matsuo S
J Am Soc Nephrol; 2000 Apr; 11(4):700-707. PubMed ID: 10752529
[TBL] [Abstract][Full Text] [Related]
12. Renal L-type fatty acid--binding protein in acute ischemic injury.
Yamamoto T; Noiri E; Ono Y; Doi K; Negishi K; Kamijo A; Kimura K; Fujita T; Kinukawa T; Taniguchi H; Nakamura K; Goto M; Shinozaki N; Ohshima S; Sugaya T
J Am Soc Nephrol; 2007 Nov; 18(11):2894-902. PubMed ID: 17942962
[TBL] [Abstract][Full Text] [Related]
13. Complement activation by tubular cells is mediated by properdin binding.
Gaarkeuken H; Siezenga MA; Zuidwijk K; van Kooten C; Rabelink TJ; Daha MR; Berger SP
Am J Physiol Renal Physiol; 2008 Nov; 295(5):F1397-403. PubMed ID: 18753294
[TBL] [Abstract][Full Text] [Related]
14. Decreased abundance of urinary exosomal aquaporin-1 in renal ischemia-reperfusion injury.
Sonoda H; Yokota-Ikeda N; Oshikawa S; Kanno Y; Yoshinaga K; Uchida K; Ueda Y; Kimiya K; Uezono S; Ueda A; Ito K; Ikeda M
Am J Physiol Renal Physiol; 2009 Oct; 297(4):F1006-16. PubMed ID: 19640902
[TBL] [Abstract][Full Text] [Related]
15. The soluble terminal complement complex (SC5b-9) up-regulates osteoprotegerin expression and release by endothelial cells: implications in rheumatoid arthritis.
Corallini F; Bossi F; Gonelli A; Tripodo C; Castellino G; Mollnes TE; Tedesco F; Rizzi L; Trotta F; Zauli G; Secchiero P
Rheumatology (Oxford); 2009 Mar; 48(3):293-8. PubMed ID: 19168833
[TBL] [Abstract][Full Text] [Related]
16. [Terminal complement complex (TTC) levels in plasma and urine from glomerular diseases: enzyme-linked immunosorbent assay (ELISA) using monoclonal antibody against neoantigens of TCC].
Kusunoki Y
Hokkaido Igaku Zasshi; 1990 Jan; 65(1):74-85. PubMed ID: 2328949
[TBL] [Abstract][Full Text] [Related]
17. Noninvasive monitoring of citrate, acetate, lactate, and renal medullary osmolyte excretion in urine as biomarkers of exposure to ischemic reperfusion injury.
Hauet T; Baumert H; Gibelin H; Hameury F; Goujon JM; Carretier M; Eugene M
Cryobiology; 2000 Dec; 41(4):280-91. PubMed ID: 11222025
[TBL] [Abstract][Full Text] [Related]
18. Demonstration of apoptosis-associated cleavage products of DNA, complement activation products SC5b-9 and C3d/dg, and immune complexes CIC-C3d, CIC-IgA, and CIC-IgG in the urine of patients with membranous glomerulonephritis.
Kotnik V; Premzl A; Skoberne M; Malovrh T; Kveder R; Kaplan-Pavlovcic S; Kotnik A; Stiblar-Martincic D
Croat Med J; 2003 Dec; 44(6):707-11. PubMed ID: 14652883
[TBL] [Abstract][Full Text] [Related]
19. Clinical analysis of perioperative complement activity during ischemia/reperfusion injury following renal transplantation.
Błogowski W; Dołęgowska B; Sałata D; Budkowska M; Domański L; Starzyńska T
Clin J Am Soc Nephrol; 2012 Nov; 7(11):1843-51. PubMed ID: 22904122
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of complement factor C5 protects against renal ischemia-reperfusion injury: inhibition of late apoptosis and inflammation.
De Vries B; Matthijsen RA; Wolfs TG; Van Bijnen AA; Heeringa P; Buurman WA
Transplantation; 2003 Feb; 75(3):375-82. PubMed ID: 12589162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
